Correlation Between Genexine and BCWORLD PHARM

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Genexine and BCWORLD PHARM at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Genexine and BCWORLD PHARM into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Genexine and BCWORLD PHARM Co, you can compare the effects of market volatilities on Genexine and BCWORLD PHARM and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genexine with a short position of BCWORLD PHARM. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genexine and BCWORLD PHARM.

Diversification Opportunities for Genexine and BCWORLD PHARM

0.19
  Correlation Coefficient

Average diversification

The 3 months correlation between Genexine and BCWORLD is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Genexine and BCWORLD PHARM Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BCWORLD PHARM and Genexine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genexine are associated (or correlated) with BCWORLD PHARM. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BCWORLD PHARM has no effect on the direction of Genexine i.e., Genexine and BCWORLD PHARM go up and down completely randomly.

Pair Corralation between Genexine and BCWORLD PHARM

Assuming the 90 days trading horizon Genexine is expected to generate 10.27 times less return on investment than BCWORLD PHARM. But when comparing it to its historical volatility, Genexine is 1.1 times less risky than BCWORLD PHARM. It trades about 0.06 of its potential returns per unit of risk. BCWORLD PHARM Co is currently generating about 0.53 of returns per unit of risk over similar time horizon. If you would invest  358,634  in BCWORLD PHARM Co on October 13, 2024 and sell it today you would earn a total of  113,366  from holding BCWORLD PHARM Co or generate 31.61% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Genexine  vs.  BCWORLD PHARM Co

 Performance 
       Timeline  
Genexine 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genexine has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Genexine is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
BCWORLD PHARM 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in BCWORLD PHARM Co are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, BCWORLD PHARM may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Genexine and BCWORLD PHARM Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Genexine and BCWORLD PHARM

The main advantage of trading using opposite Genexine and BCWORLD PHARM positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genexine position performs unexpectedly, BCWORLD PHARM can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BCWORLD PHARM will offset losses from the drop in BCWORLD PHARM's long position.
The idea behind Genexine and BCWORLD PHARM Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators